4,000 Shares in Docusign Inc. $DOCU Bought by Arista Wealth Management LLC

Key Points

• Arista Wealth Management LLC acquired 4,000 shares of Docusign Inc. valued at approximately $312,000 in the second quarter, marking a notable investment in the company.
• Several institutional investors significantly increased their stakes in Docusign during the first quarter, with Wellington Management Group's stake surging by 372.5%.
• Docusign's stock has a consensus rating of "Hold" from analysts, with a revised target price ranging from $85.00 to $95.00, reflecting potential growth expectations.

Arista Wealth Management LLC purchased a new position in Docusign Inc. (NASDAQ:DOCU - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 4,000 shares of the company's stock, valued at approximately $312,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Wellington Management Group LLP increased its stake in Docusign by 372.5% during the first quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after purchasing an additional 1,440,269 shares during the last quarter. Duquesne Family Office LLC bought a new stake in Docusign during the first quarter valued at $87,477,000. Pacer Advisors Inc. increased its stake in Docusign by 809.6% during the first quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company's stock valued at $95,017,000 after purchasing an additional 1,038,962 shares during the last quarter. Nuveen LLC bought a new stake in Docusign during the first quarter valued at $50,459,000. Finally, Victory Capital Management Inc. increased its stake in Docusign by 251.0% during the first quarter. Victory Capital Management Inc. now owns 734,588 shares of the company's stock valued at $59,795,000 after purchasing an additional 525,294 shares during the last quarter. Institutional investors own 77.64% of the company's stock.

Wall Street Analysts Forecast Growth

DOCU has been the subject of several recent research reports. Piper Sandler boosted their target price on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research note on Friday, September 5th. Royal Bank Of Canada boosted their target price on shares of Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a research note on Friday, September 5th. Argus reiterated a "hold" rating on shares of Docusign in a research note on Monday, September 8th. UBS Group set a $95.00 price target on shares of Docusign in a research report on Friday, September 5th. Finally, Wells Fargo & Company upped their price target on shares of Docusign from $80.00 to $85.00 and gave the stock an "equal weight" rating in a research report on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fifteen have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $94.14.

Insiders Place Their Bets

In related news, CFO Blake Jeffrey Grayson sold 6,500 shares of the company's stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $71.20, for a total value of $462,800.00. Following the completion of the sale, the chief financial officer owned 105,660 shares of the company's stock, valued at $7,522,992. This represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CRO Paula Hansen sold 6,000 shares of the company's stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $71.33, for a total transaction of $427,980.00. Following the completion of the sale, the executive directly owned 58,968 shares of the company's stock, valued at $4,206,187.44. The trade was a 9.24% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 102,533 shares of company stock valued at $7,709,933. Corporate insiders own 1.01% of the company's stock.

Docusign Stock Performance

Docusign stock opened at $67.93 on Friday. The company has a 50-day simple moving average of $75.02 and a 200-day simple moving average of $77.97. The firm has a market capitalization of $13.66 billion, a P/E ratio of 51.08, a P/E/G ratio of 3.34 and a beta of 1.02. Docusign Inc. has a one year low of $66.35 and a one year high of $107.86.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.08. The business had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The company's quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, sell-side analysts forecast that Docusign Inc. will post 1.17 earnings per share for the current year.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.